Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607, USA.
Trends Biochem Sci. 2018 Sep;43(9):668-684. doi: 10.1016/j.tibs.2018.06.011. Epub 2018 Jul 24.
Macrolide antibiotics inhibit protein synthesis by targeting the bacterial ribosome. They bind at the nascent peptide exit tunnel and partially occlude it. Thus, macrolides have been viewed as 'tunnel plugs' that stop the synthesis of every protein. More recent evidence, however, demonstrates that macrolides selectively inhibit the translation of a subset of cellular proteins, and that their action crucially depends on the nascent protein sequence and on the antibiotic structure. Therefore, macrolides emerge as modulators of translation rather than as global inhibitors of protein synthesis. The context-specific action of macrolides is the basis for regulating the expression of resistance genes. Understanding the details of the mechanism of macrolide action may inform rational design of new drugs and unveil important principles of translation regulation.
大环内酯类抗生素通过靶向细菌核糖体来抑制蛋白质合成。它们结合在新生肽出口隧道处,并部分阻塞它。因此,大环内酯类药物一直被视为“隧道塞子”,阻止所有蛋白质的合成。然而,最近的证据表明,大环内酯类药物选择性地抑制了一部分细胞蛋白的翻译,并且它们的作用关键取决于新生蛋白质序列和抗生素结构。因此,大环内酯类药物作为翻译调节剂出现,而不是作为蛋白质合成的全局抑制剂。大环内酯类药物的上下文特异性作用是调节耐药基因表达的基础。了解大环内酯类药物作用机制的细节可能有助于合理设计新药,并揭示翻译调控的重要原则。